Rocket Pharmaceuticals (RCKTW) Competitors $0.05 0.00 (-1.89%) Closing price 03:52 PM EasternExtended Trading$0.04 0.00 (-3.86%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock RCKTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Rocket Pharmaceuticals vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Rocket Pharmaceuticals (NASDAQ:RCKTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Does the MarketBeat Community favor RCKTW or ATNFW? Rocket Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRocket PharmaceuticalsN/AN/A180 Life SciencesN/AN/A Which has higher valuation and earnings, RCKTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRocket PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media prefer RCKTW or ATNFW? In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Rocket Pharmaceuticals and 0 mentions for 180 Life Sciences. Rocket Pharmaceuticals' average media sentiment score of 0.32 beat 180 Life Sciences' score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Rocket Pharmaceuticals Neutral 180 Life Sciences Neutral Is RCKTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Rocket PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryRocket Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKTW vs. The Competition Export to ExcelMetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$128.97M$5.33B$8.31BDividend YieldN/A3.74%5.20%4.10%P/E RatioN/A3.4226.7219.60Price / SalesN/A4,168.72395.56117.96Price / CashN/A13.1938.3234.62Price / BookN/A33.216.764.50Net IncomeN/A-$91.56M$3.23B$248.40M7 Day PerformanceN/A3.50%0.41%-1.00%1 Month PerformanceN/A7.75%9.12%10.72%1 Year PerformanceN/A102.80%18.73%9.00% Rocket Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCKTWRocket PharmaceuticalsN/A$0.05-1.9%N/A-63.8%$0.00N/A0.00240Gap DownATNFW180 Life SciencesN/A$0.01+14.8%N/A+7.1%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.10-24.2%N/AN/A$0.00$20,729.000.0040ALVOWAlvotechN/A$1.79flatN/A-36.7%$0.00$489.68M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-80.8%$0.00N/A0.0015BFRIWBiofronteraN/A$0.14+101.1%N/AN/A$0.00$37.32M0.0070Positive NewsGap UpHigh Trading VolumeBTMDWbioteN/A$0.02+43.9%N/A-94.7%$0.00$199.38M0.00N/AHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.06-14.2%N/A-80.9%$0.00N/A0.008CELUWCelularityN/A$0.04-14.2%N/A+150.0%$0.00$54.22M0.00220Gap Down Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives CELUW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCKTW) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKTW Stock Free RCKTW Stock Alerts